clofibrate and 2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid

clofibrate has been researched along with 2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujitani, H; Mitsukawa, M; Suga, T; Utsugi, M; Watanabe, T	1

Other Studies

1 other study(ies) available for clofibrate and 2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid

Article	Year
Hypolipidemic effect and enhancement of peroxisomal beta-oxidation in the liver of rats by sodium-(E)-3-(4-(3-pyridylmethyl)phenyl)-2-methyl propenoate (OKY-1581), a potent inhibitor of TxA2 synthetase. Journal of pharmacobio-dynamics, 1986, Volume: 9, Issue:12 Topics: Acrylates; Animals; Clofibrate; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Methacrylates; Microbodies; Mitochondria, Liver; Organ Size; Oxidation-Reduction; Rats; Rats, Inbred Strains; Thromboxane-A Synthase	1986

Article

Year

Hypolipidemic effect and enhancement of peroxisomal beta-oxidation in the liver of rats by sodium-(E)-3-(4-(3-pyridylmethyl)phenyl)-2-methyl propenoate (OKY-1581), a potent inhibitor of TxA2 synthetase.

Journal of pharmacobio-dynamics, 1986, Volume: 9, Issue:12

Topics: Acrylates; Animals; Clofibrate; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Methacrylates; Microbodies; Mitochondria, Liver; Organ Size; Oxidation-Reduction; Rats; Rats, Inbred Strains; Thromboxane-A Synthase

1986